跳至主要内容
临床试验/CTRI/2009/091/000112
CTRI/2009/091/000112已完成4 期

TO COMPARE THE EVALUATION OF EFFICACY, SAFETY AND TOLERABILITY OF COMBINATION OF SALBUTAMOL 2 mg + BROMHEXINE HCI 8 mg + GUAIFENESIN 100 mg (ASCORIL EXPECTORANT VS SALBUTAMOL 2 mg + GUAIFENESIN 100 mg EXPECTORANT VS SALBUTAMOL 2 mg + BROMHEXINE HCI 8 mg IN THE TREATMENT OF PRODUCTIVE COUGH ASSSOCIATED WITH ACUTE BRONCHITIS, AECB, PNEUMONIA AND ASTHMATIC BRONCHITIS IN INDIAN POPULATIO

Glenmark Pharmaceuticals LtdBD Sawant Marg, Chakala, Off. Western Express Highway, Andheri (E), Mumbai 400 0990 个研究点目标入组 354 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
354

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients of either sex 18-65 years
  • 2.Subjects giving written informed consent
  • 3.Patients with Productive Cough associated with Acute Bronchitis, AECB, Pneumonia and Asthmatic Bronchitis
  • 4.In the opinion of the investigator, able to comply with the requirements of the protocol.

排除标准

  • 1.Patients with Cystic Fibrosis
  • 2.Patients with Active Tuberculosis
  • 3.Patients with lung cancer or lung metastasis
  • 4.Patients with severe bronchiectasis
  • 5.Patients with acute respiratory decompensation
  • 6.Patients with Chronic respiratory insufficiency associated with resting hypoxemia,
  • 7.Patients requiring hospitalization for parenteral antibiotic treatment
  • 8.Patients with hypersensitivity against the medication under study
  • 9.Patients with Female patients with child bearing potential-
  • Who are pregnant
  • Who are breastfeeding
  • Who are not practicing acceptable methods of birth control

研究者

发起方
Glenmark Pharmaceuticals LtdBD Sawant Marg, Chakala, Off. Western Express Highway, Andheri (E), Mumbai 400 099

相似试验